Literature DB >> 35776168

Can we restart the rituximab after remission of rituximab-induced interstitial lung disease in malignant lymphoma?

Dongdong Zhang1, Yidi Han2, Youhong Dong2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2022        PMID： 35776168     DOI： 10.1007/s00277-022-04913-9

Source DB:  PubMed          Journal:  Ann Hematol        ISSN： 0939-5555            Impact factor:   4.030


× No keyword cloud information.
  5 in total

1.  Risk factors for rituximab-induced interstitial lung diseases in patients with malignant lymphoma.

Authors:  Seung-Ick Cha; Keum-Ju Choi; Kyung-Min Shin; Jaekwang Lim; Seung-Soo Yoo; Jaehee Lee; Shin-Yup Lee; Chang-Ho Kim; Jae-Yong Park
Journal:  Respiration       Date:  2012-12-07       Impact factor: 3.580

2.  Post-marketing safety of antineoplasic monoclonal antibodies: rituximab and trastuzumab.

Authors:  V González; E Salgueiro; F J Jimeno; A Hidalgo; T Rubio; G Manso
Journal:  Pharmacoepidemiol Drug Saf       Date:  2008-07       Impact factor: 2.890

3.  Rituximab and antimetabolite treatment of granulomatous and lymphocytic interstitial lung disease in common variable immunodeficiency.

Authors:  James W Verbsky; Mary K Hintermeyer; Pippa M Simpson; Mingen Feng; Jody Barbeau; Nagarjun Rao; Carlyne D Cool; Luis A Sosa-Lozano; Dhiraj Baruah; Erin Hammelev; Alyssa Busalacchi; Amy Rymaszewski; Jeff Woodliff; Shaoying Chen; Mary Bausch-Jurken; John M Routes
Journal:  J Allergy Clin Immunol       Date:  2020-08-01       Impact factor: 10.793

Review 4.  Rituximab-induced interstitial lung disease.

Authors:  Stephanie A Wagner; Apurva C Mehta; Damian A Laber
Journal:  Am J Hematol       Date:  2007-10       Impact factor: 10.047

5.  Systematic Review of Safety and Efficacy of Rituximab in Treating Immune-Mediated Disorders.

Authors:  Celine Kaegi; Benjamin Wuest; Jens Schreiner; Urs C Steiner; Alessandra Vultaggio; Andrea Matucci; Catherine Crowley; Onur Boyman
Journal:  Front Immunol       Date:  2019-09-06       Impact factor: 7.561
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.